Ausgabe 1/2014
Inhalt (6 Artikel)
The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer—With What Drugs and for How Long?
Stephen R. D. Johnston, Belinda Yeo
New HER2-Positive Targeting Agents in Clinical Practice
Sara Tolaney
The Application of Oncotype DX in Early-Stage Lymph-Node-Positive Disease
Sarika Jain, William J. Gradishar
Postmastectomy Radiation Therapy
Janice A. Lyons, Tracy Sherertz
Treatment of Stage II–III Rectal Cancer Patients
Miranda B. Kim, Theodore S. Hong, Jennifer Y. Wo
Palliative Treatment of Metastatic Colorectal Cancer: What is the Optimal Approach?
John H. Strickler, Herbert I. Hurwitz